SARS-CoV-2 belongs to the family of enveloped, single-strand RNA viruses known as Betacoronavirus in Coronaviridae, first reported late 2019 in China. It has since been circulating world-wide, causing the COVID-19 epidemic with high infectivity and fatality rates. As of the beginning of April 2021, pandemic SARS-CoV-2 has infected more than 130 ...The treatments available for people at the highest risk of becoming seriously ill from COVID-19 are: Nirmatrelvir plus ritonavir, remdesivir and molnupiravir are antiviral medicines. Sotrovimab is known as a neutralising monoclonal antibody (nMAb). Sotrovimab is recommended if nirmatrelvir plus ritonavir (Paxlovid) is not suitable.A Government spokesman said that the list of private doctors who have obtained COVID-19 oral drugs for prescription, namely Paxlovid and Molnupiravir, through a dedicated online platform has been published on a designated website today (April 26). The Government had earlier announced that the above two COVID-19 oral drugs would be provided to ...This drug has further been demonstrated to exert antiviral activity against Zika virus (ZIKV) in in vitro screening assays , but failed to offer protection in ZIKV-infected mice . Recently, Caly et al. reported on the antiviral activity of ivermectin against SARS-CoV-2, the causative agent of COVID-19 . These authors demonstrated that a single ...Recommendations for the use of antiviral agents to treat COVID-19 Remdesivir Information on the use of intravenous remdesivir as treatment for COVID-19 Ritonavir-Boosted Nirmatrelvir (Paxlovid) Drug interactions and other considerations for the use of ritonavir-boosted nirmatrelvir (Paxlovid) MolnupiravirPfizer’s oral antiviral drug (a combination of nirmatrelvir and ritonavir tablets) is strongly recommended for patients with non-severe COVID-19 who are at highest risk of developing severe disease and hospitalization, such as unvaccinated, older, or immunosuppressed patients.COVID-19 convalescent plasma with high titers of anti-SARS-CoV-2 antibodies is authorized for the treatment of COVID-19 in patients with immunosuppressive disease or receiving immunosuppressive ...Apr 22, 2022 · Today, WHO made a strong recommendation for nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate COVID-19 patients at highest risk of hospital admission, calling it the best therapeutic choice for high-risk patients to date. However, availability, lack of price transparency in bilateral deals made by the producer, and the need for prompt and accurate testing before ... Recommendations for the use of antiviral agents to treat COVID-19 Remdesivir Information on the use of intravenous remdesivir as treatment for COVID-19 Ritonavir-Boosted Nirmatrelvir (Paxlovid) Drug interactions and other considerations for the use of ritonavir-boosted nirmatrelvir (Paxlovid) MolnupiravirMay 26, 2023 · There is strong scientific evidence that antiviral treatment of outpatients at risk for severe COVID-19 reduces their risk of hospitalization and death.; The antiviral drugs nirmatrelvir with ritonavir (Paxlovid) and remdesivir (Veklury) are the preferred treatments for eligible adult and pediatric patients who are at high risk for progression to severe COVID-19. † Lagevrio and Paxlovid are oral antiviral therapies indicated for the treatment of patients with mild to moderate COVID-19 who have received positive results of direct SARS-CoV-2 viral testing and are at high risk for progression to severe COVID-19. Lagevrio is indicated for the treatment of adults aged ≥18 years for whom alternative COVID ...Who can and cannot take it. How and when to take it. Side effects. Pregnancy, breastfeeding and fertility. Taking Paxlovid with other medicines and herbal supplements. Aug 22, 2023 · The Panel reviews the most recent clinical data to develop treatment recommendations for clinicians who are caring for patients with COVID-19. Antivirals, Including Antibody Products These sections summarize data on the use of antiviral agents for the treatment of COVID-19. demonstrated clinical benefit for the treatment of COVID-19, the Panel recommends against the use of ivermectin for the treatment of COVID-19 (AIIa). See Table 7b for summaries of the key studies that informed the Panel’s recommendation. Drug Availability Ivermectin is not approved or authorized by the FDA for the treatment of COVID-19 ... On December 23, 2021, the FDA granted Emergency Use Authorization to Merck for it's oral antiviral drug Molnupiravir (MD-4482) to treat COVID-19. Molnupiravir is now authorized for the treatment of mild to moderate COVID-19 in adults age 18 years and older, who are at high risk for progressing to severe COVID-19 and for whom alternative COVID ...n engl j med 384;6 nejm.org February 11, 2021 499 Repurposed Antiviral Drugs for Covid-19 no trial lopinavir while they were unable to swal-low. The regimen for interferon (mainly subcuta-Reading time: 1 min (365 words) WHO has recommended two new drugs for COVID-19, providing yet more options for treating the disease. The extent to which these medicines will save lives depends on how widely available and affordable they will be. The first drug, baricitinib, is strongly recommended for patients with severe or critical COVID-19.Antiviral drugs can help your body fight off viruses like COVID-19. Learn more about forms of antivirals approved for COVID-19 treatment. The most plentiful is the antiviral drug remdesivir, sold by Gilead Sciences under the brand name Veklury.First approved by the FDA in 2020 for COVID-19 patients requiring hospitalization, Gilead ...Pfizer’s oral antiviral drug (a combination of nirmatrelvir and ritonavir tablets) is strongly recommended for patients with non-severe COVID-19 who are at highest risk of developing severe disease and hospitalization, such as unvaccinated, older, or immunosuppressed patients.Date Update Type Topic ; 5/25/2023: FDA Approves First Oral Antiviral for Treatment of COVID-19 in Adults. Today, the U.S. Food and Drug Administration approved the oral antiviral Paxlovid ...Jul 5, 2023 · If you have a Medicare card, and are eligible, the Pharmaceutical Benefits Scheme PBS subsidises the cost of oral antiviral COVID-19 medication. From 1 January 2023 the maximum that a pharmacy can charge per oral medication is: $30 for general patients. $7.30 for concession cardholders. State and territory hospitals can provide the oral ... Remdesivir has demonstrated in vitro and in vivo activity against SARS-CoV-2. 1. Intravenous remdesivir is approved by the Food and Drug Administration (FDA) for the treatment of COVID-19 in adults and pediatric patients aged ≥28 days and weighing ≥3 kg. In nonhospitalized patients with mild to moderate COVID-19 who are at high risk of ...The antiviral that doctors prefer to use to treat certain cases of COVID-19 is a pill called nirmatrelvir-ritonavir ( Paxlovid ). While Paxloid has only received emergency use authorization...Antiviral drugs can help your body fight off viruses like COVID-19. Learn more about forms of antivirals approved for COVID-19 treatment. Paxlovid (nirmatrelvir / ritonavir; co-packaged) - approved as an oral antiviral treatment for certain adults. It is used for the treatment of mild to moderate COVID-19 in adults who are at high risk for progression to severe COVID-19, including hospitalization or death. Paxlovid is not approved for use as pre-exposure or post-exposure ...COVID-19 convalescent plasma with high titers of anti-SARS-CoV-2 antibodies is authorized for the treatment of COVID-19 in patients with immunosuppressive disease or receiving immunosuppressive ...May 13, 2021 · SARS-CoV-2 belongs to the family of enveloped, single-strand RNA viruses known as Betacoronavirus in Coronaviridae, first reported late 2019 in China. It has since been circulating world-wide, causing the COVID-19 epidemic with high infectivity and fatality rates. As of the beginning of April 2021, pandemic SARS-CoV-2 has infected more than 130 ... Drugs that combat viral infections are called antiviral drugs. There are no effective antiviral drugs for many viral infections. However, there are several drugs for influenza, a couple of drugs for herpesviruses, and some new antiviral drugs for treatment of HIV and hepatitis C infections. The arsenal of antivirals is complex.Who can and cannot take it. How and when to take it. Side effects. Pregnancy, breastfeeding and fertility. Taking Paxlovid with other medicines and herbal supplements. Apr 14, 2021 · Molnupiravir is an easier-to-synthesize, oral drug option that has been found to shorten the duration of infectiousness among people with symptomatic COVID-19. Late-stage clinical testing is under ... The US Food and Drug Administration hasn't listed oseltamivir in its drug shortage database, but the agency did acknowledge "localized shortages" of the drug on Dec 5. Drug restocking date uncertain Antiviral therapy is an important adjunct to vaccination in the prevention and control of the flu and can reduce the duration of flu symptoms and ...Dec 2, 2020 · n engl j med 384;6 nejm.org February 11, 2021 499 Repurposed Antiviral Drugs for Covid-19 no trial lopinavir while they were unable to swal-low. The regimen for interferon (mainly subcuta- The Swiss company Molecular Partners has developed an antiviral drug for Covid-19, called ensovibep. The drug is a custom-made protein, made up of three sections that can each grab onto a ...Nov 30, 2021 · Molnupiravir, an antiviral drug to treat mild to moderate COVID-19, is under consideration by the FDA for possible authorization. Merck. A Food and Drug Administration advisory committee voted ... The FDA also has approved the rheumatoid arthritis drugs baricitinib (Olumiant) and tocilizumab (Actemra) to treat COVID-19 in some cases. Baricitinib is a pill that seems to work against COVID-19 by reducing inflammation and having antiviral activity. Tocilizumab is an injection.Currently, humans are immersed in a pandemic caused by the emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which threatens public health worldwide. To date, no drug or vaccine has been approved to treat the severe disease caused by this coronavirus, COVID-19. In this paper, we will focus on the main virus-based and host-based targets that can guide efforts in medicinal ...Apr 22, 2022 · Today, WHO made a strong recommendation for nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate COVID-19 patients at highest risk of hospital admission, calling it the best therapeutic choice for high-risk patients to date. However, availability, lack of price transparency in bilateral deals made by the producer, and the need for prompt and accurate testing before ... Nov 25, 2021 · The quest for effective drugs to treat COVID-19 has been a priority since the outbreak of the disease. The clinical application of remdesivir has been greatly restricted by the need for intravenous administration, as well as unstable concentrations in plasma and variable antiviral activity in different organelles.1 Four neutralising antibodies (bamlanivimab, etesevimab, casirivimab, and ... From these results, it is evident that the use of these drugs for COVID-19 requires further investigation. An alternative treatment for COVID-19 is the utilization of convalescent plasma (CP) (Chen L. et al., 2020). This treatment refers to plasma therapy based on plasma or plasma derivatives, obtained from donors who were previously infected ...These sections summarize the data on antiviral agents, including remdesivir, ritonavir-boosted nirmatrelvir, and anti-SARS-CoV-2 monoclonal antibodies. Antivirals, Including Antibody Products | COVID-19 Treatment Guidelines Apr 19, 2022 · 19 Apr 2022 06:56PM (Updated: 19 Apr 2022 07:32PM) SINGAPORE: The antiviral drug molnupravir will be the second oral medicine approved in Singapore for the treatment of adult COVID-19 patients ... Together, 2 antiviral drugs, nirmatrelvir and ritonavir (brand name Pfizer-Paxlovid ®), are authorized to treat adults with mild to moderate COVID-19 who show symptoms and are at high risk of serious illness, including hospitalization or death. This is the first authorized COVID-19 treatment that people can take orally at home.Jun 17, 2021 · And if the history of antiviral research is any guide, the first drugs for Covid-19 will probably only offer modest benefit against the disease, Dr. Fauci said. But that would be a good start. Jul 14, 2023 · developing a COVID-19 plan if you test positive to COVID-19. Learn more about oral antiviral treatments for COVID-19. Older Australians and First Nations people. If you test positive for COVID-19, you may be eligible for antiviral treatments if you are: 70 years of age or older, regardless of risk factors and with or without symptoms. The FDA authorized two antivirals, Pfizer's Paxlovid and Merck's molnupiravir, for the treatment of COVID-19 in certain patients. Hospital Treatments for COVID-19 There are treatments for hospitalized patients with severe cases of COVID-19 that have been approved or authorized for emergency use by the Food and Drug Administration (FDA).Wear a Mask mask. If you become infected with COVID-19, there are treatment options that may help reduce how sick you become. The U.S. Food and Drug Administration has authorized and approved treatments that have already been taken by millions of people, reducing their risk of severe COVID-19 symptoms and keeping many of them out of the hospital.Pfizer Covid pills may be risky with other medications. Dec. 26, 202106:39. In its fact sheet about Paxlovid, the FDA has published a detailed list of medications that may interact harmfully with ...The FDA authorized two antivirals, Pfizer's Paxlovid and Merck's molnupiravir, for the treatment of COVID-19 in certain patients. Hospital Treatments for COVID-19. There are treatments for hospitalized patients with severe cases of COVID-19 that have been approved or authorized for emergency use by the Food and Drug Administration (FDA). COVID-19. Pfizer. 3C-like protease inhibitor (Nirmatrelvir) / inhibition of metabolism of nirmatrelvir (ritonavir) Nevirapine. HIV. non- nucleoside reverse transcriptase inhibitor. Nitazoxanide. Broad-spectrum antiviral. The treatments available for people at the highest risk of becoming seriously ill from COVID-19 are: Nirmatrelvir plus ritonavir, remdesivir and molnupiravir are antiviral medicines. Sotrovimab is known as a neutralising monoclonal antibody (nMAb). Sotrovimab is recommended if nirmatrelvir plus ritonavir (Paxlovid) is not suitable.SARS-CoV-2 belongs to the family of enveloped, single-strand RNA viruses known as Betacoronavirus in Coronaviridae, first reported late 2019 in China. It has since been circulating world-wide, causing the COVID-19 epidemic with high infectivity and fatality rates. As of the beginning of April 2021, pandemic SARS-CoV-2 has infected more than 130 ...Many medications are available to treat COVID-19, including oral treatments like Paxlovid (nirmatrelvir / ritonavir) and Lagevrio (molnupiravir). In late May 2023, the FDA fully approved Paxlovid for COVID-19. It’s the first oral antiviral that is approved to treat the condition. It was previously only available for emergency use. The COVID-19 is affecting thousands of peoples day by day and continues to spread across the world. The present review has focused on promising repurposing drugs, including remdesivir, lopinvar/retinovar, favipiravir, hydroxychloroquine, monoclonal antibodies and vaccines against the SARS-CoV-2 infection. Besides, our review has also focused on many organizations that are in the race to ...Veklury is a COVID-19 treatment given intravenously (by IV or drip). Like oral antivirals, Veklury helps stop the virus that causes COVID-19 from making copies of itself in your body. WHO is eligible to receive Veklury? Adults 18 and over; Children who are 28 days of age or older and weigh at least 7 pounds (3 kg) AND who: Reading time: 1 min (365 words) WHO has recommended two new drugs for COVID-19, providing yet more options for treating the disease. The extent to which these medicines will save lives depends on how widely available and affordable they will be. The first drug, baricitinib, is strongly recommended for patients with severe or critical COVID-19.Feb 28, 2022 · Collection of documents relating to COVID-19 treatments. The NHS is offering new antibody and antiviral treatments to people with coronavirus (COVID-19) who are at highest risk of becoming ... Veklury is a COVID-19 treatment given intravenously (by IV or drip). Like oral antivirals, Veklury helps stop the virus that causes COVID-19 from making copies of itself in your body. WHO is eligible to receive Veklury? Adults 18 and over; Children who are 28 days of age or older and weigh at least 7 pounds (3 kg) AND who:Feb 4, 2023 · The antiviral Paxlovid has changed the battle against COVID-19. It's so effective that more than 85% of people at risk for severe disease can avoid a bad outcome with a five-day course of the ... Feb 28, 2022 · Collection of documents relating to COVID-19 treatments. The NHS is offering new antibody and antiviral treatments to people with coronavirus (COVID-19) who are at highest risk of becoming ... Paxlovid is one of the only antiviral pills to effectively treat COVID-19 symptoms. ... the herbal remedy St. John's Wort, and HIV medications. (A complete list of those drugs starts on page 11 of ...Mar 30, 2022 · Ivermectin for Early Covid-19 Multiple medications in common use have been considered for the treatment of Covid-19. In this double-blind, randomized, placebo-controlled trial, ivermectin that was ... Aug 25, 2023 · Antivirals are medicines that help stop a virus infecting healthy cells or multiplying in the body. There are antivirals available that work against COVID-19 and they work best when taken as soon as possible. COVID-19 antivirals do not work against other viruses like the flu. There are different antivirals for the flu. Dec 16, 2021 · Abstract Background New treatments are needed to reduce the risk of progression of coronavirus disease 2019 (Covid-19). Molnupiravir is an oral, small-molecule antiviral prodrug that is active agai... Paxlovid is a swallowable tablet that stops the COVID-19 virus from replicating and progressing to a more severe state. Most recently, the drug was approved by the Food and Drug Administration (FDA) to treat mild to moderate COVID-19 in adults (people 18 and older) who are at high risk for developing severe COVID-19.Nov 16, 2022 · This section describes trends in the use of COVID-19 medications that have been shown to be effective in lowering risk for severe health outcomes, including COVID-19–related deaths. Data presented are from PCORnet , a network of healthcare facilities that contains electronic health record data for over 30 million people. Jun 17, 2021 · And if the history of antiviral research is any guide, the first drugs for Covid-19 will probably only offer modest benefit against the disease, Dr. Fauci said. But that would be a good start. On Sept. 27, Pfizer said that it was launching a late-phase clinical trial to test whether, in combination with another drug, its oral COVID-19 antiviral can prevent infection with the coronavirus ...Dec 2, 2020 · n engl j med 384;6 nejm.org February 11, 2021 499 Repurposed Antiviral Drugs for Covid-19 no trial lopinavir while they were unable to swal-low. The regimen for interferon (mainly subcuta- † Lagevrio and Paxlovid are oral antiviral therapies indicated for the treatment of patients with mild to moderate COVID-19 who have received positive results of direct SARS-CoV-2 viral testing and are at high risk for progression to severe COVID-19. Lagevrio is indicated for the treatment of adults aged ≥18 years for whom alternative COVID ...Oct 15, 2021 · On Sept. 27, Pfizer said that it was launching a late-phase clinical trial to test whether, in combination with another drug, its oral COVID-19 antiviral can prevent infection with the coronavirus ... Mar 30, 2022 · Ivermectin for Early Covid-19 Multiple medications in common use have been considered for the treatment of Covid-19. In this double-blind, randomized, placebo-controlled trial, ivermectin that was ... Influenza and COVID-19. The worldwide pandemic of the disease called COVID-19 has changed the way people look at “flu-like” symptoms. COVID-19 is caused by a different virus, not an influenza ...Antivirals are medicines that help stop a virus infecting healthy cells or multiplying in the body. There are antivirals available that work against COVID-19 and they work best when taken as soon as possible. COVID-19 antivirals do not work against other viruses like the flu. There are different antivirals for the flu.A Government spokesman said that the list of private doctors who have obtained COVID-19 oral drugs for prescription, namely Paxlovid and Molnupiravir, through a dedicated online platform has been published on a designated website today (April 26). The Government had earlier announced that the above two COVID-19 oral drugs would be provided to ...Jul 21, 2023 · Remdesivir has demonstrated in vitro and in vivo activity against SARS-CoV-2. 1. Intravenous remdesivir is approved by the Food and Drug Administration (FDA) for the treatment of COVID-19 in adults and pediatric patients aged ≥28 days and weighing ≥3 kg. In nonhospitalized patients with mild to moderate COVID-19 who are at high risk of ... Here are 15 herbs with powerful antiviral activity. 1. Oregano. Oregano is a popular herb in the mint family that’s known for its impressive medicinal qualities. Its plant compounds, which ...Paxlovid is one of the only antiviral pills to effectively treat COVID-19 symptoms. ... the herbal remedy St. John's Wort, and HIV medications. (A complete list of those drugs starts on page 11 of ...There are currently two oral antiviral pills, Paxlovid and Lagevrio, authorized for emergency use for the treatment of certain patients with mild to moderate COVID-19. Data have shown that the...Who can and cannot take it. How and when to take it. Side effects. Pregnancy, breastfeeding and fertility. Taking Paxlovid with other medicines and herbal supplements. Two new oral antiviral medications are available for treatment of COVID-19. Two new antiviral medications, ritonavir-boosted nirmatrelvir (Paxlovid, ie, nirmatrelvir-ritonavir) and molnupiravir (Lagevrio), are currently available in the US under emergency use authorization. These 2 drugs are authorized for treatment of patients with mild to ...There are two antiviral medications that have been issued Emergency Use Authorization (EUA) by the U.S. FDA: Pfizer’s Paxlovid and Merck’s molnupiravir. Both treatments are in limited supply, and a prescription does not guarantee the medication will be available. Treatment should be initiated as soon as possible after diagnosis of COVID-19 ...On December 23, 2021, the FDA granted Emergency Use Authorization to Merck for it's oral antiviral drug Molnupiravir (MD-4482) to treat COVID-19. Molnupiravir is now authorized for the treatment of mild to moderate COVID-19 in adults age 18 years and older, who are at high risk for progressing to severe COVID-19 and for whom alternative COVID ...
The most plentiful is the antiviral drug remdesivir, sold by Gilead Sciences under the brand name Veklury.First approved by the FDA in 2020 for COVID-19 patients requiring hospitalization, Gilead .... Dollar1000 to pounds
There are two oral antiviral therapies currently available to treat Covid-19 in the United States. One, called Paxlovid, was developed by Pfizer and was the first oral treatment authorized for ...n engl j med 384;6 nejm.org February 11, 2021 499 Repurposed Antiviral Drugs for Covid-19 no trial lopinavir while they were unable to swal-low. The regimen for interferon (mainly subcuta-Date Update Type Topic ; 5/25/2023: FDA Approves First Oral Antiviral for Treatment of COVID-19 in Adults. Today, the U.S. Food and Drug Administration approved the oral antiviral Paxlovid ...Jul 14, 2023 · developing a COVID-19 plan if you test positive to COVID-19. Learn more about oral antiviral treatments for COVID-19. Older Australians and First Nations people. If you test positive for COVID-19, you may be eligible for antiviral treatments if you are: 70 years of age or older, regardless of risk factors and with or without symptoms. Who can and cannot take it. How and when to take it. Side effects. Pregnancy, breastfeeding and fertility. Taking Paxlovid with other medicines and herbal supplements.Molnupiravir, an antiviral drug to treat mild to moderate COVID-19, is under consideration by the FDA for possible authorization. Merck. A Food and Drug Administration advisory committee voted ...Feb 4, 2023 · The antiviral Paxlovid has changed the battle against COVID-19. It's so effective that more than 85% of people at risk for severe disease can avoid a bad outcome with a five-day course of the ... Dec 21, 2021 · Ibuprofen, which is also known by the brand names Advil and Motrin, is a non-steroidal anti-inflammatory drug (NSAID). These types of medications can help lower your fever and minimize muscle aches from COVID-19, while also reducing some inflammation in your body. Ibuprofen doesn’t treat the virus itself, but it can make you feel a lot better. May 26, 2023 · To access the Letters of Authorization and Fact Sheets for Healthcare Providers and Patients, Parents, and Caregivers for EUAs for drug and biological products during the COVID-19 pandemic, see ... Currently, humans are immersed in a pandemic caused by the emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which threatens public health worldwide. To date, no drug or vaccine has been approved to treat the severe disease caused by this coronavirus, COVID-19. In this paper, we will focus on the main virus-based and host-based targets that can guide efforts in medicinal ...The NHS is offering new antibody and antiviral treatments to people with coronavirus (COVID-19) who are at highest risk of becoming seriously ill. See treatments for coronavirus for further ...There are two oral antiviral therapies currently available to treat Covid-19 in the United States. One, called Paxlovid, was developed by Pfizer and was the first oral treatment authorized for ...Many medications are available to treat COVID-19, including oral treatments like Paxlovid (nirmatrelvir / ritonavir) and Lagevrio (molnupiravir). In late May 2023, the FDA fully approved Paxlovid for COVID-19. It’s the first oral antiviral that is approved to treat the condition. It was previously only available for emergency use. Date Update Type Topic ; 5/25/2023: FDA Approves First Oral Antiviral for Treatment of COVID-19 in Adults. Today, the U.S. Food and Drug Administration approved the oral antiviral Paxlovid ... developing a COVID-19 plan if you test positive to COVID-19. Learn more about oral antiviral treatments for COVID-19. Older Australians and First Nations people. If you test positive for COVID-19, you may be eligible for antiviral treatments if you are: 70 years of age or older, regardless of risk factors and with or without symptoms.Wear a Mask mask. If you become infected with COVID-19, there are treatment options that may help reduce how sick you become. The U.S. Food and Drug Administration has authorized and approved treatments that have already been taken by millions of people, reducing their risk of severe COVID-19 symptoms and keeping many of them out of the hospital. Mar 30, 2022 · Ivermectin for Early Covid-19 Multiple medications in common use have been considered for the treatment of Covid-19. In this double-blind, randomized, placebo-controlled trial, ivermectin that was ... .